bpc-157 human trials safety evidence BPC-157: Experimental Peptide Creates Risk for Athletes bpc-157 human clinical trials evidence
Description
Simultaneously, it shortens the telogen phase, meaning follicles return to active growth more quickly
BPC-157 is widely studied in tissue repair (tendon, ligament, muscle, bone), gastrointestinal protection (ulcers, IBD, leaky gut), neuroprotection, cardiovascular research, and wound healing
Reviews describe regenerative and protective actions, roles in skin regeneration, and modulation of multiple cellular pathways but this is largely mechanistic and preclinical work, not large human efficacy trials
Si le patient souffre d'une maladie virale ou fongique, des mdicaments antiviraux ou antifongiques doivent tre ajouts
